Mallinckrodt looks for higher sales growth in Japan
This article was originally published in Clinica
Executive Summary
Mallinckrodt Medical is considering forming a joint venture or making an acquisition in Japan in order to achieve its growth target in that market. Its current sales of around $100 million are growing more slowly than the company would like, reports Japan Medical Review. By 2000, Mallinckrodt aims to see 10% annual sales growth in Japan, says Michael Rocca, the company's vice-president and CFO.